Literature DB >> 7750283

The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring.

E Weisberg1, I S Fraser, D R Mishell, M Lacarra, C W Bardin.   

Abstract

The acceptability of a vaginal ring releasing ethinyl oestradiol 20 mcg per day and norethindrone acetate 1 mg per day was assessed during a six-month phase II trial comparing three different regimens, which was carried out simultaneously in Los Angeles and Sydney. Sixty women were enrolled in Sydney and 90 in Los Angeles. On admission into the study, the women were asked to complete a questionnaire which gave details of age, last contraceptive method used, contraceptive methods used in the past and their reason for liking or disliking previous contraceptive methods, as well as their reason for stopping the last method. On completion of the study or leaving the study for any reason, each woman was asked to complete an acceptability questionnaire which included her experiences with the ring and the rating of the method. The responses to these two questionnaires form the basis of this report. The overall rating of the ring was similar in both the Sydney and Los Angeles groups. Sixty-nine percent of women rated the method as very good. Seventy-two percent of women in Los Angeles and 62% of women in Sydney liked the ring much more than their most liked previous method. In both groups the method they liked best apart from the ring was the pill (62% in Sydney and 53% in Los Angeles). The major reasons for liking the ring were convenience of use, effectiveness and no requirements for taking medication daily. Most women in both studies would recommend the ring to others (92% in Sydney and 89% in Los Angeles).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750283     DOI: 10.1016/0010-7824(94)00005-h

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Adolescent experiences with the vaginal ring.

Authors:  Laura B Epstein; Karen Sokal-Gutierrez; Susan L Ivey; Tina Raine; Colette Auerswald
Journal:  J Adolesc Health       Date:  2008-03-10       Impact factor: 5.012

2.  Systemic effects of vaginally administered estrogen therapy: a review.

Authors:  Megan Krause; Thomas L Wheeler; Holly E Richter; Thomas E Snyder
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-05       Impact factor: 2.091

3.  Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.

Authors:  Kathleen Ridgeway; Elizabeth T Montgomery; Kevin Smith; Kristine Torjesen; Ariane van der Straten; Sharon L Achilles; Jennifer B Griffin
Journal:  Contraception       Date:  2021-10-10       Impact factor: 3.051

Review 4.  Vaginal rings for menopausal symptom relief.

Authors:  Susan A Ballagh
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction.

Authors:  Ruth B Merkatz; Marlena Plagianos; Elena Hoskin; Michael Cooney; Paul C Hewett; Barbara S Mensch
Journal:  Contraception       Date:  2014-06-02       Impact factor: 3.375

6.  Attitudes toward the vaginal ring and transdermal patch among adolescents and young women.

Authors:  Tina R Raine; Laura B Epstein; Cynthia C Harper; Beth A Brown; Cherrie B Boyer
Journal:  J Adolesc Health       Date:  2009-05-30       Impact factor: 5.012

Review 7.  Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis.

Authors:  Thérèse Delvaux; Vicky Jespers; Lenka Benova; Janneke van de Wijgert
Journal:  Front Glob Womens Health       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.